TickerFacts.

Protagenic Therapeutics, Inc.\new (PTIX): Capital Expenditures

Annual figures by period end, from SEC filings.

$3.3K
Year ended 2026-03-31
$149.8K2022-12-31: $1.8K2023-12-31: $149.8K2026-03-31: $3.3K$3.3K
2022-12-31 Capital Expenditures (USD) 2026-03-31
Period endedCapital ExpendituresChange YoYSource filing
2026-03-31$3.3Kn/a2026-08-14, From 2025-04-01
No annual figure between 2023-12-31 and 2026-03-31.
2023-12-31$149.8Kn/m2025-03-31, From 2023-01-01
2022-12-31$1.8Kn/a2024-05-14, From 2022-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Protagenic Therapeutics, Inc.\new (PTIX)2026-03-31$3.3Kn/a
Palatin Technologies Inc (PTN)2025-06-30$0-100.0%
Pulmatrix, Inc. (PULM)2024-12-31$398.0K-41.1%
Lexaria Bioscience Corp. (LEXX)2025-08-31$24.6K-42.7%
Cadrenal Therapeutics, Inc. (CVKD)2025-12-31$5.1K-21.9%
Alaunos Therapeutics, Inc. (TCRT)2025-12-31$98.0Kn/a
Neonc Technologies Holdings, Inc. (NTHI)2025-12-31$500.0Kn/a
International Stem Cell Corp (ISCO)2025-12-31$43.0K-74.1%
Azitra, Inc. (AZTR)2025-12-31$24.2K+182.6%

Compare PTIX, PTN, PULM, LEXX side by side · Screen every company in Pharmaceutical Preparations ↗